Olympus and Proximie Forge Partnership to Transform Digital Healthcare

By Melike Belenli Gümüş

October 29, 2024

The press release from Olympus Europa highlights a significant partnership between Olympus Corporation and Proximie, a global health technology company. This collaboration is centred around Proximie’s innovative health tech platform, which aims to digitise operating rooms and enhance patient care. The newly formed partnership is designed to improve patient outcomes and clinical practices by fostering collaboration and knowledge sharing among healthcare professionals.

Partnership Overview

Olympus Corporation has entered a global partnership with Proximie to offer a market-leading health tech platform that focuses on digitising operating rooms. This partnership is essential for improving patient care and enhancing clinical practices through better collaboration among medical staff.

Proximie’s Platform

Proximie’s cloud-based solution enables physicians to share real-time live clinical video, audio, and imagery from the operating room (OR) with colleagues and vendor partners globally. This facilitates telecollaboration, secure training sessions, and the capture of video content from any source.

Key Features of Proximie’s Platform

The platform is designed to be device-agnostic, enabling compatibility with various devices and allowing access from any browser or mobile device. It supports up to four high-definition, low-latency video feeds, providing essential views of procedures. To facilitate real-time collaboration, the platform includes features such as annotation, chat, and screen sharing. Moreover, the platform streamlines installation by offering tablet control and the ability to connect multiple video signals, making it easy to set up in any tower or clinical space. For moderation and privacy, the platform incorporates comprehensive controls and privacy features to manage sessions effectively. Furthermore, the system offers content management capabilities, allowing users to transform individual expertise into shareable video content.

Regional Agreement

In the EMEA region, Olympus and Proximie have entered into a Reseller Partner Agreement. This partnership allows Olympus to distribute Proximie’s health tech platform products. Customers across Europe, the Middle East, and Africa will now have access to these innovative solutions.

Objectives and Benefits

The partnership aims to break down learning barriers, providing healthcare professionals with the knowledge needed to enhance patient care. The initiative aims to promote clinical and operational best practices by increasing teaching opportunities. It seeks to reach a broader audience of learners. The collaboration plays a crucial role in the future of digital healthcare. Surgeons can meet the rising demand for diagnostic and interventional care, thereby improving global healthcare equity.

Statements from Executives

Engin Demirel, Global Head of Commercialization for Endoscopy Solutions Ecosystem (ESE) at Olympus Corporation, expressed excitement about the partnership, highlighting its potential to improve patient outcomes. Dr. Nadine Hachach-Haram, the Proximie founder and CEO, emphasised the shared commitment to widening access to surgical and procedural knowledge through the health tech platform, ultimately improving global healthcare equity.

About Olympus and Proximie

Olympus: A global medical technology company committed to making people’s lives healthier, safer, and more fulfilling. Olympus partners with healthcare professionals to deliver best-in-class solutions for early detection, diagnosis, and minimally invasive treatment.

Proximie: A global health technology platform focused on digitising operating and diagnostic rooms. The goal of Proximie’s health tech platform is to make surgery more accessible, efficient, and effective through cutting-edge, cloud-based technology.

Reference url

Recent Posts

ivonescimab lung cancer treatment
       

Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer

🚀 🌍 Ivonescimab’s NMPA approval for PD-L1+ NSCLC reshapes oncology!

This chemo-free bispecific antibody outperforms pembrolizumab, boosting PFS/OS in the HARMONi-2 trial. Its dual-action mechanism sets a new standard, driving urgency for market access and policy strategies. Discover why this breakthrough matters for global NSCLC care (and more indications in the pipeline).

Dive into the full article [here] (https://www.akesobio.com/en/media/akeso-news/250426/).

#SyenzaNews #oncology #HealthcareInnovation #PharmaInnovation #NSCLC

CDC hepatitis lab closure
         

Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure

🚨 Is the abrupt closure of the CDC’s only hepatitis lab leaving the U.S. vulnerable during an ongoing outbreak?

This article looks into the ramifications of the CDC hepatitis lab closure amid federal layoffs, questioning the impact on outbreak detection and public health. With the lab’s unique capabilities being irreplaceable, what does this mean for our response to hepatitis outbreaks?

Explore the critical insights and implications for our public health infrastructure.

#SyenzaNews #HealthcareInnovation #HealthEconomics #PublicHealth

peanut oral immunotherapy
        

Promising Results for Peanut Oral Immunotherapy

🌟 Ready to change the conversation on peanut allergies?

A recent study from the University of Virginia shines a light on peanut oral immunotherapy (epOIT), revealing that 90% of young children achieved effective desensitization with minimal side effects. This compelling research advocates for early intervention, potentially transforming how we manage this prevalent food allergy.

Dive into the full article to explore how adopting this approach could reshape health policies and enhance quality of life for affected families.

#SyenzaNews #HealthTech #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.